Cargando…
Current microfluidic platforms for reverse engineering of cornea
According to the World Health Organization, corneal blindness constitutes 5.1% of global blindness population. Surgical outcomes have been improved significantly in the treatment of corneal blindness. However, corneal transplantation is limited by global shortage of donor tissue, prompting researche...
Autores principales: | Li, Qinyu, Wong, Ho Lam, Ip, Yan Lam, Chu, Wang Yee, Li, Man Shek, Saha, Chinmoy, Shih, Kendrick Co, Chan, Yau Kei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149412/ https://www.ncbi.nlm.nih.gov/pubmed/37139464 http://dx.doi.org/10.1016/j.mtbio.2023.100634 |
Ejemplares similares
-
Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond
por: Bu, Yashan, et al.
Publicado: (2019) -
Engineering Microfluidic Organoid-on-a-Chip Platforms
por: Yu, Fang, et al.
Publicado: (2019) -
A Review of the Impact of Alterations in Gut Microbiome on the Immunopathogenesis of Ocular Diseases
por: Bu, Yashan, et al.
Publicado: (2021) -
Tissue Engineering the Cornea: The Evolution of RAFT
por: Levis, Hannah J., et al.
Publicado: (2015) -
A Proposed Framework for Machine Learning-Aided Triage in Public Specialty Ophthalmology Clinics in Hong Kong
por: Li, Yalsin Yik Sum, et al.
Publicado: (2021)